| 规格 | 10ug |
|---|---|
| 表达宿主 | E.coli |
| 标签 | NA |
| 分子量 | 7.8 KDa |
|---|---|
| 表观分子量 | 9-12 KDa, reducing conditions |
| 形态 | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
| 纯度 | Greater than 95% as determined by reducing SDS-PAGE. |
| 内毒素水平 | Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. |
|---|
| 溶解方法 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| 储存方法 | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
| 背景说明 | Human Chemokine (C-C Motif) Ligand 5 (CCL5) plays an active role in recruiting leukocytes into inflammatory sites. CCL5 is secreted by many cell types at inflammatory sites and it exerts a wide range of activities through the receptors CCR1, CCR3, CCR4, and CCR5. N-Terminal truncated CCL5/RANTES, Met-RANTES, and amino-oxypentane (AOP)-RANTES exhibit antagonist or partial agonist functions on their receptors. CCL5/RANTES attracts different subtypes of leukocytes into inflamed tissue and intervenes in a wide range of allergic and autoimmune diseases. |
|---|
| 产品名称 | 点击数 |
|---|---|
| 人弓形虫抗原 | 4086 |
| 柯萨奇重组抗原Coxsackie 柯萨奇 | 1568 |
| HSV-I疱疹I型 | 1259 |
| HSV-II疱疹II型 | 1355 |
| Rubella风疹 | 1481 |
| HCMV巨细胞 | 1562 |
| MYO 肌红蛋白 Myoglobin抗原抗体 | 1317 |
| HP 分型检测抗原 | 1340 |
| 肺炎支原体 | 1209 |
| 麻疹抗原 | 1330 |
| 腮腺炎 | 1392 |
| 脊髓灰质炎 | 1225 |
| 百日咳 | 1277 |
| HIV 艾滋检测 | 1291 |
| ZIKV 寨卡病毒 | 1615 |
| Human parvovirus 人细小B19病毒 | 1348 |
| Dengue 登革热抗原 | 1364 |
| Chikungunya 切昆贡亚 | 1306 |
| 丝虫病重组抗原 | 1398 |
| 丙型肝炎病毒(HCV) | 1584 |